Delivery Order SPE2DR25D1106-SPE2DR26FJF7H
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,593.60 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on December 23, 2025, with completion expected by December 24, 2025. This award represents a firm fixed price, competitively awarded delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,868.93 to AmerisourceBergen Drug Corp for Fycompa (perampanel) 0.5 mg/mL oral suspension in a 340 mL quantity. This is a firm fixed price delivery order with an ultimate completion date of December 24, 2025, issued on December 23, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,148.08 by the Defense Logistics Agency on August 5, 2025, for the supply of Fycompa 4 mg tablets (30-count). This firm fixed-price delivery order, which concludes on August 6, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Fycompa 8 mg tablets (30-count units) valued at $2,984.13 with firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,081.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Fycompa 8 mg tablets (30-count packaging). This delivery order, which serves as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA, is scheduled for completion by October 28, 2025, and represents part of the company's ongoing pharmaceutical distribution services to federal healthcare systems. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units) under a firm fixed-price contract valued at $1,150.70. This competitively awarded, non-set-aside delivery order, issued on December 30, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 31, 2025. The delivery order represents a discrete purchase...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fycompa (perampanel) 4 mg tablets, quantity 30, with a ceiling value of $4,004.04 under a firm fixed price contract type. The award was made on December 9, 2025, with an ultimate completion date of December 10, 2025. This non-set-aside contract represents a routine pharmaceutical procurement through the federal supply chain, with performance at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $4,169.69 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 6 mg tablets (30-count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,261.97 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 340ml of 0.5mg/ml oral suspension of FYCOMPA. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 7, 2023. No set aside designation was applied to this order, which was awarded against an indefinite delivery contract held by...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF7HDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Fycompa 0.5 mg/mL oral suspension in a 340 mL quantity, with a firm fixed price ceiling value of $3,946.57 and an ultimate completion date of January 2, 2026. This is a competitive, non-set-aside award with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company serves federal customers including the Defense Health Agency and U.S. Coast Guard through its DLA Troop Support prime contract, which represents a strategic sourcing vehicle designed to provide flexible pharmaceutical support to military healthcare systems. The current delivery order for Fycompa, a neurological treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/30/25 |